It has become an important force in the international market. The worry is that the market is in a state of disorder and it needs to improve the security and competitive benefit.
In 2010, composed by the 4 major classifications of dietary supplements, natural organic food, natural care products and functional foods make up a global nutrition market size is about f $ 210.4 billion. It is expected that in the next 10 years the annual development rate will go beyond 8%; the global plant extracts product with annual sales of $ 6.5 billion, the growth rate of about 20% higher than the drugs.
The very first major exporter of Chinese plant extracts is the United States accounting for exports of 30.06%. The 21.82% are exported to Europe, 16.86% are exported to Japan. Plant extracts benefit of China’s huge plant resources and reasonably low operating costs. Boost of the total trend of worldwide aging and the natural demand for drugs will continue to provide a big market area, which supplies development chances for China’s plant extracts. Plant extracts come from farming products, development of the industry will be able to drive a brand-new kind of rural advancement.
At the same time, the plant extract industry must be standardized. Initially, Chinese plant extracts the current level of competition is fairly low, uncoordinated with the export volume of the market continued to increase. Company size is fairly small, generally 2 billion to 3 billion in sales; low level of cost competitors in between business, in spite of the current exports are rising, but profit margins have actually been falling. Second, the plant extracts in the department in charge of standards, the legal status of the three noes state. No standards and no legal status, making the market the limit is very low, resulting in an increase of a great deal of little irinotecan companies, and likewise planted a covert danger for the safety of items. Third, the technological material of export varieties is reasonably low and the trademarked product is not rich. Most crude exports are reasonably low-end. The Chinese plant extracts do not have of worldwide competitiveness mainly due to plant resource restrictions, backward extraction process, the lower the level of equipment, along with brand-new R & & D investment less.
Enterprises should enhance the technological material of products to raise revenue margins. Plant extracts are still relatively little scale and lack of benchmark enterprises with high visibility. Chinese enterprises can select the way of the advancement of a complete industrial chain to build development companies, plant extracts is the primary basic material for health products. Chinese enterprises can emulate the API maker to do the preparations the production of health items.
Plant extracts has fast development in the irregulatory environment. Chinese enterprises normally familiar with the seriousness of the industry norms and self-control. The country started to pay more attention to the development of this chia seed market. For medication extract’s foreign market need, China ought to focus on assistance demand, high tech and comprehensive utilization-oriented. They can promote the expertise of Chinese medication market with independent copyright rights and market competitiveness of Chinese medication basic extract industry, the formation of the extract of 20 sort of traditional Chinese medicine has a competitive benefit in the market standard
< img src ="http://net711.win/diet/wp-content/uploads/2021/06/58Mhh9.gif" alt ="Free Reprint Articles" border ="0"/ >, the new Chinese medicine standard extract exports worth $ 200 million. The sales are 2 billion RMB in China.Source: http://www.cospcn.com Plant Based Diet Plan